Microporation applications for enhancing drug delivery

Expert Opinion on Drug Delivery

Volumn 6, Issue 4, 2009, Pages 343-354

  Banga, Ajay K ^a  

^a MERCER UNIVERSITY   (United States)

Author keywords

Laser ablation; Microneedles; Microporation; Radiofrequency ablation; Thermal ablation; Transdermal delivery

Indexed keywords

ALBUMIN; CHONDROITIN SULFATE; DEXTRIN; ERYTHROPOIETIN; MALTOSE; POLYMER;

BIODEGRADABILITY; DISPOSABLE EQUIPMENT; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG TRANSPORT; ELASTICITY; HIGH TEMPERATURE; IMMUNOGENICITY; LASER SURGERY; MACROMOLECULE; MASS IMMUNIZATION; MAXIMUM PLASMA CONCENTRATION; MEDICAL TECHNOLOGY; MICRONEEDLE; MICROPORATION; NANOFABRICATION; NEEDLE; RADIOFREQUENCY ABLATION; REVIEW; TRANSDERMAL PATCH;

ADMINISTRATION, CUTANEOUS; ANIMALS; CATHETER ABLATION; DRUG DELIVERY SYSTEMS; HUMANS; LASER THERAPY; MICROINJECTIONS; NEEDLES; PHARMACEUTICAL PREPARATIONS; SKIN ABSORPTION; TECHNOLOGY, PHARMACEUTICAL;

EID: 67649096926     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425240902841935     Document Type: Review

References (87)

1. Cross SE, Roberts MS. Physical enhancement of transdermal drug application: is delivery technology keeping up with pharmaceutical development? Curr Drug Deliv 2004;1:81-92
2. Nanda A, Nanda S, Ghilzai NM. Current developments using emerging transdermal technologies in physical enhancement methods. Curr Drug Deliv 2006;3:233-242 (Pubitemid 44031622)
3. Banga AK. New technologies to allow transdermal delivery of therapeutic proteins and small water-soluble drugs. Am J Drug Deliv 2006;4:221-230 (Pubitemid 46307153)
4. Banga AK. Therapeutic peptides and proteins: formulation, processing, and delivery systems. Boca Raton London New York: Taylor and Francis, 2006; p. 1-354
5. Prausnitz MR. Overcoming skin's barrier: the search for effective and user-friendly drug delivery. Diabetes Technol Ther 2001;3:233-236 (Pubitemid 32651959)
6. Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol 2008;26:1261-1268
7. Henry S, McAllister DV, Allen MG, et al. Microfabricated microneedles: A novel approach to transdermal drug delivery. J Pharm Sci 1998;87:922-925 (Pubitemid 28381247)
8. Sivamani RK, Stoeber B, Wu GC, et al. Clinical microneedle injection of methyl nicotinate: stratum corneum penetration. Skin Res Technol 2005;11:152-156 (Pubitemid 40542856)
9. Roxhed N, Samel B, Nordquist L, et al. Painless drug delivery through microneedle-based transdermal patches featuring active infusion. IEEE Trans Biomed Eng 2008;55:1063-1071 • This paper presents a microneedle patch integrated with a drug reservoir and reports that microneedle insertion in human subjects was not painful. (Pubitemid 351301214)
10. Wermeling DP, Banks SL, Hudson DA, et al. Microneedles permit transdermal delivery of a skin-impermeant medication to humans. Proc Natl Acad Sci USA 2008;105:2058-2063
11. Bal SM, Caussin J, Pavel S, et al. In vivo assessment of safety of microneedle arrays in human skin. Eur J Pharm Sci 2008;35:193-202
12. Banks SL, Pinninti RR, Gill HS, et al. Flux across microneedle-treated skin is increased by increasing charge of naltrexone and naltrexol in vitro. Pharm Res 2008;25:1677-1685
13. Li G, Badkar A, Nema S, et al. In vitro transdermal delivery of therapeutic antibodies using maltose microneedles. Int J Pharm 2009;368:109-115
14. Ito Y, Hagiwara E, Saeki A, et al. Feasibility of microneedles for percutaneous absorption of insulin. Eur J Pharm Sci 2006;29:82-88 (Pubitemid 44279397)
15. Martanto W, Davis SP, Holiday NR, et al. Transdermal delivery of insulin using microneedles in vivo. Pharm Res 2004;21:947-952 (Pubitemid 38870143)
16. Davis SP, Martanto W, Allen MG, et al. Hollow metal microneedles for insulin delivery to diabetic rats. IEEE Trans Biomed Eng 2005;52:909-915 (Pubitemid 40675490)
17. Nordquist L, Roxhed N, Griss P, et al. Novel microneedle patches for active insulin delivery are efficient in maintaining glycaemic control: an initial comparison with subcutaneous administration. Pharm Res 2007;24:1381-1388 (Pubitemid 46870597)
18. Matriano JA, Cormier M, Johnson J, et al. Macroflux microprojection array patch technology: a new and efficient approach for intracutaneous immunization. Pharm Res 2002;19:63-70 (Pubitemid 34075108)
19. Widera G, Johnson J, Kim L, et al. Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system. Vaccine 2006;24:1653-1664 (Pubitemid 43238242)
20. Mikszta JA, Dekker JP III, Harvey NG, et al. Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine. Infect Immun 2006;74:6806-6810 (Pubitemid 44913155)
21. McAllister DV, Allen MG, Prausnitz MR. Microfabricated microneedles for gene and drug delivery. Annu Rev Biomed Eng 2000;2:289-313
22. Chabri F, Bouris K, Jones T, et al. Microfabricated silicon microneedles for nonviral cutaneous gene delivery. Br J Dermatol 2004;150:869-877 (Pubitemid 38903518)
23. Pearton M, Allender C, Brain K, et al. Gene delivery to the epidermal cells of human skin explants using microfabricated microneedles and hydrogel formulations. Pharm Res 2008;25:407-416 (Pubitemid 351257969)
24. Prausnitz MR. Microneedles for transdermal drug delivery. Adv Drug Deliv Rev 2004;56:581-587 (Pubitemid 38326934)
25. Sivamani RK, Liepmann D, Maibach HI. Microneedles and transdermal applications. Expert Opin Drug Deliv 2007;4:19-25
26. McAllister DV, Wang PM, Davis SP, et al. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies. Proc Natl Acad Sci USA 2003;100:13755-13760 (Pubitemid 37499139)
27. Coulman SA, Anstey A, Gateley C, et al. Microneedle mediated delivery of nanoparticles into human skin. Int J Pharm 2009;366:190-200 • This study investigates the delivery of nanoparticles into/across microporated skin and the various factors associated with it.
28. Gill HS, Prausnitz MR. Coating formulations for microneedles. Pharm Res 2007;24:1369-1380 (Pubitemid 46870599)
29. Gill HS, Prausnitz MR. Coated microneedles for transdermal delivery. J Control Release 2007;117:227-237 • A good study which investigates a novel coating technique for microneedles with application to a wide range of therapeutic moieties. (Pubitemid 46161873)
30. Rodriguez A, Molinero D, Valera E, et al. Fabrication of silicon oxide microneedles from macroporous silicon. Sens Actuators B 2005;109:135-140 (Pubitemid 41042596)
31. Paik S, Byun S, Lim J, et al. In-plane single-crystal-silicon microneedles for minimally invasive microfluid systems. Sens Actuators A 2004;114:276-284
32. Mukerjee EV, Collins SD, Isseroff RR, et al. Microneedle array for transdermal biological fluid extraction and in situ analysis. Sens Actuators A 2004;114:267-275
33. Available from: http://www.halozyme.com [Accessed February 2009]
34. Wang PM, Cornwell M, Hill J, et al. Precise microinjection into skin using hollow microneedles. J Invest Dermatol 2006;126:1080-1087
35. Martanto W, Moore JS, Kashlan O, et al. Microinfusion using hollow microneedles. Pharm Res 2006;23:104-113 (Pubitemid 43214666)
36. Martanto W, Moore JS, Couse T, et al. Mechanism of fluid infusion during microneedle insertion and retraction. J Control Release 2006;112:357-361 (Pubitemid 43737149)
37. Roxhed N, Griss P, Stemme G. Membrane-sealed hollow microneedles and related administration schemes for transdermal drug delivery. Biomed Microdevices 2008;10:271-279 (Pubitemid 351337929)
38. Shawgo R, Grayson A, Li Y, et al. BioMEMS for drug delivery. Curr Opin Solid State Mat Sci 2002;6:329-334 (Pubitemid 36374742)
39. Tao SL, Desai TA. Microfabricated drug delivery systems: from particles to pores. Adv Drug Deliv Rev 2003;55:315-328 (Pubitemid 36293790)
40. Hilt JZ, Peppas NA. Microfabricated drug delivery devices. Int J Pharm 2005;306:15-23 (Pubitemid 41643137)
41. Wu Y, Qiu Y, Zhang S, et al. Microneedle-based drug delivery: studies on delivery parameters and biocompatibility. Biomed Microdevices 2008;10:601-610
42. Coulman S, Allender C, Birchall J. Microneedles and other physical methods for overcoming the stratum corneum barrier for cutaneous gene therapy. Crit Rev Ther Drug Carrier Syst 2006;23:205-258 (Pubitemid 44950092)
43. Kuo S, Chou Y. A novel polymer microneedle arrays and PDMS micromolding technique. Tamkang J Sci Engg 2004;7:95-98
44. Miyano T, Tobinaga Y, Kanno T, et al. Sugar micro needles as transdermic drug delivery system. Biomed Microdevices 2005;7:185-188 (Pubitemid 41236286)
45. Kolli CS, Banga AK. Characterization of solid maltose microneedles and their use for transdermal delivery. Pharm Res 2008;25:104-113 • A study which investigates the use of soluble maltose microneedles for potentially safe and effective drug delivery.
46. Vemulapalli V, Yang Y, Friden PM, et al. Synergistic effect of iontophoresis and soluble microneedles for transdermal delivery of methotrexate. J Pharm Pharmacol 2008;60:27-33
47. Ito Y, Yoshimitsu J, Shiroyama K, et al. Self-dissolving microneedles for the percutaneous absorption of EPO in mice. J Drug Target 2006;14:255-261 (Pubitemid 44173291)
48. Lee JW, Park JH, Prausnitz MR. Dissolving microneedles for transdermal drug delivery. Biomaterials 2008;29:2113-2124
49. Park JH, Allen MG, Prausnitz MR. Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. J Control Release 2005;104:51-66 (Pubitemid 40615235)
50. Park JH, Allen MG, Prausnitz MR. Polymer microneedles for controlled-release drug delivery. Pharm Res 2006;23:1008-1019 (Pubitemid 43781409)
51. Available from: http://www.zosanopharma.com [Accessed February 2009]
52. Hansen K, Haldin B. Transdermal delivery: a solid microstructured transdermal system (sMTS) for systemic delivery of salts and proteins. Drug Deliv Technol 2008;8:38-42
53. Hansen K, Simons J, Peterson T. Transdermal delivery of high volume liquid formulations using hollow microstructures. Presented at the Annual Meeting of the American Associatiion of Pharmaceutical Scientists, November 16-20, 2008, Atlanta, GA; 2008
54. Hansen K, Simons J, Peterson T. Transdermal delivery of non-traditional APIs for systemic delivery using solid microstructures. Presented at the Annual Meeting of the American Association of Pharmaceutical Scientists, November 16-20, 2008, Atlanta, GA; 2008
55. Sivamani RK, Stoeber B, Liepmann D, et al. Microneedle penetration and injection past the stratum corneum in humans. J Dermatolog Treat 2008;1-4
56. Teo MA, Shearwood C, Ng KC, et al. In vitro and in vivo characterization of MEMS microneedles. Biomed Microdevices 2005;7:47-52
57. Davis SP, Landis BJ, Adams ZH, et al. Insertion of microneedles into skin: measurement and prediction of insertion force and needle fracture force. J Biomech 2004;37:1155-1163 • A well designed study which investigates the various parameters/forces associated with insertion of microneedles into skin. (Pubitemid 38798369)
58. Verbaan FJ, Bal SM, van den Berg DJ, et al. Improved piercing of microneedle arrays in dermatomed human skin by an impact insertion method. J Control Release 2008;128:80-88
59. Oh JH, Park HH, Do KY, et al. Influence of the delivery systems using a microneedle array on the permeation of a hydrophilic molecule, calcein. Eur J Pharm Biopharm 2008;69:1040-1045
60. Levin G, Gershonowitz A, Sacks H, et al. Transdermal delivery of human growth hormone through RF-microchannels. Pharm Res 2005;22:550-555 • This paper uses a novel radio-frequency ablation approach to achieve skin microporation and reports delivery of a protein, human growth hormone, with a bioavailability as high as 75%, relative to subcutaneous injection. (Pubitemid 40603252)
61. Lin W, Cormier M, Samiee A, et al. Transdermal delivery of antisense oligonucleotides with microprojection patch (Macroflux) technology. Pharm Res 2001;18:1789-1793 (Pubitemid 34020438)
62. Kolli C, Kalluri H, Farquhar D, et al. Effect of occlusion and formulation pH on pore closure in vivo following microneedle pretreatment. Presented at the Annual Meeting of the American Association of Pharmaceutical Scientists, November 16-20, 2008, Atlanta, GA; 2008
63. Zhai H, Maibach HI. Occlusion vs. skin barrier function. Skin Res Technol 2002;8:1-6 (Pubitemid 34555457)
64. Kennish L, Reidenberg B. A review of the effect of occlusive dressings on lamellar bodies in the stratum corneum and relevance to transdermal absorption. Dermatol Online J 2005;11:7 (Pubitemid 43034783)
65. Park JH, Lee JW, Kim YC, et al. The effect of heat on skin permeability. Int J Pharm 2008;359:94-103
66. Available from: http://www.alteatherapeutics.com [Accessed February 2009]
67. Badkar AV, Smith AM, Eppstein JA, et al. Transdermal delivery of interferon alpha-2B using microporation and iontophoresis in hairless rats. Pharm Res 2007;24:1389-1395 (Pubitemid 46876496)
68. Bramson J, Dayball K, Evelegh C, et al. Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines. Gene Ther 2003;10:251-260 (Pubitemid 36204414)
69. Smith A, Yang D, Delcher H, et al. Fluorescein kinetics in interstitial fluid harvested from diabetic skin during fluorescein angiography: implications for glucose monitoring. Diabetes Technol Ther 1999;1:21-27
70. Birchall J, Coulman S, Anstey A, et al. Cutaneous gene expression of plasmid DNA in excised human skin following delivery via microchannels created by radio frequency ablation. Int J Pharm 2006;312:15-23
71. Sintov AC, Krymberk I, Daniel D, et al. Radiofrequency-driven skin microchanneling as a new way for electrically assisted transdermal delivery of hydrophilic drugs. J Control Release 2003;89:311-320 (Pubitemid 36507024)
72. Available from: http://www.transpharmamedical.com; [Accessed February 2009]
73. Kalia YN, Bachhav YG, Bragagna T, et al. Intraepidermal Delivery: P.L.E.A.S.E., a new laser microporation technology. Drug Deliv Technol 2008;8:26-31
74. Bachhav YG, Summer S, Heinrich A, et al. P.L.E.A.S.E: A promising tool for intraepidermal drug delivery. Presented at the Annual Meeting of the Controlled Release Society, July 2008, New York, NY; 2008
75. Weimann LJ, Wu J. Transdermal delivery of poly-l-lysine by sonomacroporation. Ultrasound Med Biol 2002;28:1173-1180 (Pubitemid 35215094)
76. Herndon TO, Gonzalez S, Gowrishankar TR, et al. Transdermal microconduits by microscission for drug delivery and sample acquisition. BMC Med 2004;2:12 (Pubitemid 39111866)
77. Fang JY, Lee WR, Shen SC, et al. Enhancement of topical 5-aminolaevulinic acid delivery by erbium:YAG laser and microdermabrasion: a comparison with iontophoresis and electroporation. Br J Dermatol 2004;151:132-140 (Pubitemid 39061290)
78. Banga AK, Chien YW. Iontophoretic delivery of drugs: fundamentals, developments and biomedical Applications. J Control Release 1988;7:1-24 (Pubitemid 18108772)
79. Banga AK. Theme section: transdermal delivery of proteins. Pharm Res 2007;24:1357-1359 (Pubitemid 46870603)
80. Wu XM, Todo H, Sugibayashi K. Enhancement of skin permeation of high molecular compounds by a combination of microneedle pretreatment and iontophoresis. J Control Release 2007;118:189-195 (Pubitemid 46329739)
81. Qiu Y, Gao Y, Hu K, et al. Enhancement of skin permeation of docetaxel: a novel approach combining microneedle and elastic liposomes. J Control Release 2008;129:144-150
82. Cormier M, Johnson B, Ameri M, et al. Transdermal delivery of desmopressin using a coated microneedle array patch system. J Control Release 2004;97:503-511 (Pubitemid 38802952)
83. Badran MM, Kuntsche J, Fahr A. Skin penetration enhancement by a microneedle device (Dermaroller) in vitro: dependency on needle size and applied formulation. Eur J Pharm Sci 2009;36:511-523
84. Frolich MA, Giannotti A, Modell JH. Opioid overdose in a patient using a fentanyl patch during treatment with a warming blanket. Anesth Analg 2001;93:647-648 (Pubitemid 32783289)
85. Kuhlman JJ Jr, McCaulley R, Valouch TJ, et al. Fentanyl use, misuse, and abuse: a summary of 23 postmortem cases. J Anal Toxicol 2003;27:499-504 (Pubitemid 37185862)
86. Wokovich AM, Prodduturi S, Doub WH, et al. Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute. Eur J Pharm Biopharm 2006;64:1-8 (Pubitemid 44150598)
87. Available from: http://www.pantec-biosolutions.com